VitaNova Life Sciences VNOV
OTC VNOV
$1.38 +0.00 (+0.00%)
At close: Sep 16, 2026 · 4:00 PM EDT

VitaNova Life Sciences (VNOV) Interest Expenses (2024 - 2025)

VitaNova Life Sciences' (VNOV) quarterly Interest Expenses came in at $1568.0 in Q2 2025, up 92.87% on a QoQ basis from $813.0 in Q1 2025.

Analysis

VitaNova Life Sciences (VNOV) Interest Expenses (2024 - 2025) Analysis & Trends

VitaNova Life Sciences has disclosed Interest Expenses across 2 years of filings, most recently posting $1568.0 for Q2 2025.

  • Interest Expenses for Q2 2025 came in at $1568.0, changed N/A year-over-year; the trailing twelve-month figure through Apr 2026 was $1568.0 (down 65.2% YoY), and the FY2025 annual result was $4506.0, changed N/A from the prior year.
  • Interest Expenses for Q2 2025 stood at $1568.0, up from $813.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $2125.0 in Q4 2024 and bottomed at $813.0 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Accenture 120.96 Bn 111.91 Bn 6.13 Bn 70.65 Mn
2 UL Solutions 12.94 Bn 12.53 Bn 417.00 Mn 5.00 Mn
3 Gartner 11.74 Bn 10.25 Bn 1.19 Bn 22.27 Mn
4 Booz Allen Hamilton Holding 9.28 Bn 8.74 Bn 1.46 Bn -
5 Tetra Tech 9.14 Bn 8.91 Bn 243.21 Mn 7.16 Mn
6 Genpact 5.74 Bn 5.22 Bn 490.34 Mn -
7 Grand Canyon Education 3.97 Bn 3.69 Bn 204.08 Mn -
8 Fti Consulting 3.91 Bn 3.74 Bn 316.27 Mn 11.63 Mn
9 Korn Ferry 3.90 Bn 3.09 Bn 681.29 Mn -
10 VitaNova Life Sciences 11.51 Mn 9.90 Mn 30,521.00 -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2025 1,568.00
Jan 31, 2025 813.00
Oct 31, 2024 2,125.00